C12N 2710/10044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/10044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 12 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 20
- Assignees
- 13
- Inventors
- 48
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 2 | 0 |
| 2022 | 2 | 2 |
| 2023 | 0 | 0 |
| 2024 | 3 | 4 |
| 2025 | 2 | 1 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Adenoviral vector22 Jul 2025US 12,365,920 B2Oxford University Innovation Limited
- AAV-IDUA vector for treatment of MPS I-associated blindness21 Jan 2025US 12,201,697 B2The University of North Carolina at Chapel Hill
- PSMA-based molecular-genetic reporter system1 Oct 2024US 12,104,214 B2The Johns Hopkins University
- Adenoviral vector30 Apr 2024US 11,970,709 B2Oxford University Innovation Limited
- Simian adenovirus and hybrid adenoviral vectors2 Jan 2024US 11,857,640 B2Oxford University Innovation Limited
- Packaging plasmids for aav production3 Sep 2026US 2026/0258449 A1Biogen MA Inc.
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Adenoviral helper plasmid16 Jul 2026US 2026/0201418 A1Forge Biologics, Inc.
- Modified mammalian cells for improved production2 Jul 2026US 2026/0185120 A1Genzyme Corporation
- Methods of raav packaging12 Jun 2025US 2025/0188490 A1University of Massachusetts
Most cited
By later US patents
- Simian adenovirus and hybrid adenoviral vectors21US 9,714,435 B2Oxford University Innovation Limited · 2017
- Simian adenovirus and hybrid adenoviral vectors3US 10,646,587 B2Oxford University Innovation Limited · 2020
- Canine adenovirus vectors1US 10,329,586 B2Boehringer Ingelheim Vetmedica GmbH · 2019
- Adenoviral vector1US 11,306,325 B2Oxford University Innovation Limited · 2022